Evercore ISI's Mark Mahaney joins Yahoo Finance Live to discuss the future of Twitter after CEO Jack Dorsey stepped down yesterday and the hurdles the social media company faces in product development and advertising tools. Read More...
Morningstar Research
Analyst Report: Merck & Co., Inc.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm’s immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, close to half of the firm’s sales are generated in the United States.
